192 related articles for article (PubMed ID: 8196823)
1. Erythromycin-induced torsades de pointes and ventricular fibrillation in a patient with Legionella pneumonia.
de Koning J; van der Hoeven H; Hamer B; Thompson J
Neth J Med; 1994 Apr; 44(4):131-5. PubMed ID: 8196823
[TBL] [Abstract][Full Text] [Related]
2. [Access of torsades de pointes in Legionnaires' disease: an uncommon adverse effect of erythromycin].
Staikowsky F; Haziza F; Guidet B; Vassal T; Offenstadt G
Rev Pneumol Clin; 1991; 47(2):92-4. PubMed ID: 1759106
[TBL] [Abstract][Full Text] [Related]
3. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
Oberg KC; Bauman JL
Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
[TBL] [Abstract][Full Text] [Related]
4. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
Lin JC; Quasny HA
Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
[TBL] [Abstract][Full Text] [Related]
5. Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user.
Atkinson D; Dunne A; Parker M
Anaesthesia; 2007 Sep; 62(9):952-5. PubMed ID: 17697226
[TBL] [Abstract][Full Text] [Related]
6. Erythromycin induced torsades de pointes.
Wong CB; Windle J
Nebr Med J; 1995 Sep; 80(9):285-6. PubMed ID: 7566254
[TBL] [Abstract][Full Text] [Related]
7. Erythromycin induced Torsades de Pointes: case report and review of the literature.
Rezkalla MA; Pochop C
S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
[TBL] [Abstract][Full Text] [Related]
8. A case series of drug-induced long QT syndrome and Torsade de Pointes.
Tong KL; Lau YS; Teo WS
Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
[TBL] [Abstract][Full Text] [Related]
9. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia].
Lengyel C; Várkonyi T; Fazekas T
Orv Hetil; 1997 Apr; 138(16):1003-6. PubMed ID: 9153994
[TBL] [Abstract][Full Text] [Related]
10. Clinical study of amiodarone-associated torsade de pointes in Chinese people.
Geng DF; Jin DM; Wang JF; Luo YJ; Wu W
Pacing Clin Electrophysiol; 2006 Jul; 29(7):712-8. PubMed ID: 16884506
[TBL] [Abstract][Full Text] [Related]
11. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review.
Brandriss MW; Richardson WS; Barold SS
Clin Infect Dis; 1994 Jun; 18(6):995-8. PubMed ID: 8086567
[TBL] [Abstract][Full Text] [Related]
12. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
Wysowski DK; Corken A; Gallo-Torres H; Talarico L; Rodriguez EM
Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817
[TBL] [Abstract][Full Text] [Related]
13. Torsades de pointes due to drug interaction between disopyramide and clarithromycin.
Choudhury L; Grais IM; Passman RS
Heart Dis; 1999; 1(4):206-7. PubMed ID: 11720625
[TBL] [Abstract][Full Text] [Related]
14. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
[TBL] [Abstract][Full Text] [Related]
15. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
Makai A; Rudas L; Liszkai G; Fazekas T
Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
[TBL] [Abstract][Full Text] [Related]
17. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
[TBL] [Abstract][Full Text] [Related]
19. [Ventricular pro-arrhythmic effects of anti-arrhythmia drugs].
Jaillon P; Simon T
Therapie; 1992; 47(3):187-92. PubMed ID: 1295119
[TBL] [Abstract][Full Text] [Related]
20. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
Pearson EC; Woosley RL
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
